Learning Objectives:

1. Identify patients at risk for advanced liver disease 

2. Understand impact of lifestyle intervention and weight loss

3. Discuss available medications with concomitant benefit in NASH

4. Describe future therapy options 

Session date: 
11/01/2022 - 7:00am to 8:00am CDT
Downtown Practice Primary Care
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Alan L. Hutchison, MD, PhD and Mary E. Rinella, MD